Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion type Assertion NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_head.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion description "[We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_provenance.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion evidence source_evidence_literature NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_provenance.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion SIO_000772 20974589 NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_provenance.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion wasDerivedFrom befree-20140225 NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_provenance.
- NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_assertion wasGeneratedBy ECO_0000203 NP628422.RAqEf_Wm_lUPaZg2KAt57Fqj9WdY1DtO7Ig_RckA7T8CQ130_provenance.